產品詳情
簡單介紹：
Anti-FXYD7抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-FXYD7抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-FXYD7
Cat. Number:
Anti-FXYD7抗體KL-13235R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This reference sequence was derived from multiple replicate ESTs and validated by similar human genomic sequence. This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conservedAnti-FXYD7抗體 amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. This gene product, FXYD7, is novel and has not been characterized as a protein. [RefSeq curation by Kathleen J. Sweadner, Ph.D., sweadner@helix.mgh.harvard.edu., Dec 2000].
Also known as:
FLJ25096; FXYD domain containing ion Anti-FXYD7抗體transport regulator 7; FXYD domain-containing ion transport regulator 7; Fxyd7; FXYD7_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human FXYD7.
●
Predicted Molecular Weight: Anti-FXYD7抗體9kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-FXYD7抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-FXYD7抗體
Optimal working dilutions must be determined by the end user.
kl553Mu01 基質金屬蛋白酶9(MMP9)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl553Po01 基質金屬蛋白酶9(MMP9)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl553Ra01 基質金屬蛋白酶9(MMP9)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl554Ra01 尼克酰胺腺嘌呤二核苷酸磷酸氧化酶1(NOX1)多克隆抗體 Polyclonal Antibody to Nicotinamide Adenine Dinucleotide Phosphate Oxidase 1 (NOX1)
kl556Hu01 角蛋白7(KRT7)多克隆抗體 Polyclonal Antibody to Keratin 7 (KRT7)
kl557Hu01 甲狀腺過氧化物酶(TPO)多克隆抗體 Polyclonal Antibody to Thyroid Peroxidase (TPO)
kl557Ra01 甲狀腺過氧化物酶(TPO)多克隆抗體 Polyclonal Antibody to Thyroid Peroxidase (TPO)
kl558Hu01 端粒酶關聯蛋白1(TEP1)多克隆抗體 Polyclonal Antibody to Telomerase Associated Protein 1 (TEP1)
kl559Hu01 腸型脂肪酸結合蛋白(FABP2)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 2, Intestinal (FABP2)
kl559Mu01 腸型脂肪酸結合蛋白(FABP2)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 2, Intestinal (FABP2)
kl559Ra01 腸型脂肪酸結合蛋白(FABP2)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 2, Intestinal (FABP2)
kl561Mu01 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl561Ra01 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl563Bo01 白介素1β(IL1β)多克隆抗體 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Ca01 白介素1β(IL1β)多克隆抗體 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Eq01 白介素1β(IL1β)多克隆抗體 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Ga01 白介素1β(IL1β)多克隆抗體 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Gu01 白介素1β(IL1β)多克隆抗體 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
